• SurveyMonkey Raises $180 Million in U.S. IPO

    21 days ago - By Fortune

    Online-polling company SurveyMonkey raised $180 million in an upsized initial public offering, selling the shares above the marketed price range.
    SurveyMonkey, the operating name of Svmk Inc., sold 15 million shares for $12 apiece after earlier offering 13.5 million of them for $9 to $11, according to a statement Tuesday. Concurrent with the offering, the company also sold $40 million in stock to Salesforce.com Inc.'s venture capital arm. Based on the IPO price the company will have a market valuation of $1.46 billion.
    SurveyMonkey is older than many of its newly public peers, having been...
    Read more ...

     

  • SurveyMonkey Raises $180 Million in U.S. IPO

    21 days ago - By Fortune

    Online-polling company SurveyMonkey raised $180 million in an upsized initial public offering, selling the shares above the marketed price range.
    SurveyMonkey, the operating name of Svmk Inc., sold 15 million shares for $12 apiece after earlier offering 13.5 million of them for $9 to $11, according to a statement Tuesday. Concurrent with the offering, the company also sold $40 million in stock to Salesforce.com Inc.'s venture capital arm. Based on the IPO price the company will have a market valuation of $1.46 billion.
    SurveyMonkey is older than many of its newly public peers, having been...
    Read more ...

     

  • SurveyMonkey Goes Public, and Demand Is High: What to Watch Today

    21 days ago - By NY Times

    The parent company of the online pollster priced its initial public offering above expectations. Expect Wall Street investors to want a piece.
    Read more ...

     

  • Tilray just inked another cannabis supply agreement - and shares are surging once again

    Tilray just inked another cannabis supply agreement - and shares are surging once again

    21 days ago - By Business Insider

    Tilray said Wednesday it had increased the amount of dried marijuana it will purchase from Supreme Cannabis, from 2 million Canadian dollars to 12 million.
    Shares of Tilray surged on the news, while Supreme was mostly flat in early trading.
    Follow Tilray's stock price in real-time here.
    Tilray is surging in early trading Wednesday after announcing it had inked a deal to buy 12 million Canadian dollars worth of dried cannabis from Supreme Cannabis for its medical marijuana business.
    The agreement is a significant increase in the value of dried cannabis that Tilray originally agreed to...
    Read more ...

     

  • SurveyMonkey prices its IPO at $12 a share

    SurveyMonkey prices its IPO at $12 a share

    21 days ago - By Business Insider

    SurveyMonkey priced its initial public offering at $12 a share.
    The IPO raised $180 million through the sale of 15 million shares.
    The company had previously sought a sale of 13.5 million shares.
    SurveyMonkey announced Tuesday that it had priced its initial public offering at $12 a share, raising $180 million through the sale of 15 million shares.
    The survey provider previously sought the sale of 13.5 million shares through its IPO, which was expected to price in the range of $9 to $11 per share, according to Reuters. However, the size was increased due to robust investor demand.
    In its...
    Read more ...

     

  • SurveyMonkey prices its IPO at $12 a share

    SurveyMonkey prices its IPO at $12 a share

    21 days ago - By Business Insider

    SurveyMonkey priced its initial public offering at $12 a share.
    The IPO raised $180 million through the sale of 15 million shares.
    The company had previously sought a sale of 13.5 million shares.
    SurveyMonkey announced Tuesday that it had priced its initial public offering at $12 a share, raising $180 million through the sale of 15 million shares.
    The survey provider previously sought the sale of 13.5 million shares through its IPO, which was expected to price in the range of $9 to $11 per share, according to Reuters. However, the size was increased due to robust investor demand.
    In its...
    Read more ...